Centogene N.V. (CNTG) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Centogene N.V. has amended its loan agreement with Lifera to extend the maturity date and is negotiating potential accounts receivable financing, which is contingent on approval by senior lender Oxford Finance LLC. The firm is also exploring strategic alternatives such as mergers or additional financing, with its current cash reserves projected to last through the second quarter of 2024. Amid these developments, Centogene is delaying its Annual Report on Form 20-F filing, seeking a 15-day extension due to ongoing financial discussions.
For further insights into CNTG stock, check out TipRanks’ Stock Analysis page.